Phase 2 Study of Abemaciclib (LY2835219) in Dedifferentiated Liposarcoma
Latest Information Update: 11 Jun 2025
At a glance
- Drugs Abemaciclib (Primary)
- Indications Liposarcoma
- Focus Therapeutic Use
Most Recent Events
- 05 Jun 2025 Planned End Date changed from 1 Jul 2025 to 1 Jul 2026.
- 05 Jun 2025 Planned primary completion date changed from 1 Jul 2025 to 1 Jul 2026.
- 02 Aug 2024 Planned End Date changed from 1 Jul 2024 to 1 Jul 2025.